V014-2970 Screening compound: N-{2-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-N-[3-(morpholin-4-yl)propyl]-4-(trifluoromethyl)benzamide

V014-2970 Screening compound: N-{2-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-N-[3-(morpholin-4-yl)propyl]-4-(trifluoromethyl)benzamide
V014-2970 Screening compound: N-{2-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-N-[3-(morpholin-4-yl)propyl]-4-(trifluoromethyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V014-2970
N-{2-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-N-[3-(morpholin-4-yl)propyl]-4-(trifluoromethyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V014-2970

Molecular Formula

C25H26BrF3N4O3 (C25 H26 BrF3 N4 O3)

Compound Name

N-{2-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-N-[3-(morpholin-4-yl)propyl]-4-(trifluoromethyl)benzamide

IUPAC name

N-{2-[3-(4-bromophenyl)-124-oxadiazol-5-yl]ethyl}-N-[3-(morpholin-4-yl)propyl]-4-(trifluoromethyl)benzamide

SMILES

O=C(c1ccc(C(F)(F)F)cc1)N(CCCN1CCOCC1)CCc1nc(-c(cc2)ccc2Br)no1

InChI

InChI=1S/C25H26BrF3N4O3/c26-21-8-4-18(5-9-21)23-30-22(36-31-23)10-13-33(12-1-11-32-14-16-35-17-15-32)24(34)19-2-6-20(7-3-19)25(27,28)29/h2-9H,1,10-17H2

InChI Key

HXMWLWSYHMHHPM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19786748

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

567.41

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.962

Distribution Coefficient, logD

4.739

Water Solubility, LogSw

-4.91

Polar Surface Area

59.369

Acid Dissociation Constant (pKa)

27.84

Base Dissociation Constant (pKb)

7.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

V014-2970 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

PI3K-Targeted Library (17255 compounds)

Antibacterial Compounds Library (13827 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Immune system
  • animal
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V014-2970 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V014-2970?
Check Price and Availability of V014-2970, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V014-2970 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V014-2970
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V014-2970
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V014-2970 available by request